LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

LLY

922.39

-1.51%↓

JNJ

186.29

-0.03%↓

UNH

324.11

+0.82%↑

NVS

126.28

-0.09%↓

ABT

126.19

+1.02%↑

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

1.23 4.24

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

1.19

Max

1.23

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+158.62% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2025. g. 12. nov.

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	55M 63M
Iepriekšējā atvēršanas cena	-3.01
Iepriekšējā slēgšanas cena	1.23

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 7. nov. 21:06 UTC

Galvenie tirgus virzītāji

JBS Down After Trump Calls for Probe into Meat-Packing Companies

2025. g. 7. nov. 22:36 UTC

Peļņas

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

2025. g. 7. nov. 22:22 UTC

Peļņas

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Rev $2.95B >CSU.T

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q Net $210M >CSU.T

2025. g. 7. nov. 22:03 UTC

Peļņas

Constellation Software 3Q EPS $9.89 >CSU.T

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 7. nov. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 7. nov. 20:59 UTC

Peļņas

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

2025. g. 7. nov. 20:26 UTC

Tirgus saruna

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

2025. g. 7. nov. 20:22 UTC

Peļņas

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

2025. g. 7. nov. 20:04 UTC

Tirgus saruna

Oil Futures Close Choppy Week With Losses -- Market Talk

2025. g. 7. nov. 19:34 UTC

Tirgus saruna

Gold Posts Small Gain for Week -- Market Talk

2025. g. 7. nov. 19:31 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

2025. g. 7. nov. 19:17 UTC

Peļņas

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

2025. g. 7. nov. 19:09 UTC

Peļņas

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

2025. g. 7. nov. 19:08 UTC

Peļņas

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

2025. g. 7. nov. 18:31 UTC

Tirgus saruna

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

2025. g. 7. nov. 17:27 UTC

Tirgus saruna

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2025. g. 7. nov. 17:20 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair Expects to Complete Purchase in Early 2026

2025. g. 7. nov. 17:17 UTC

Iegādes, apvienošanās, pārņemšana

Satair: Deal Includes Unical's and ecube's Seven Operational Sites and Offices, With Combined 2024 Rev of $298M and Headcount of 413

2025. g. 7. nov. 17:15 UTC

Iegādes, apvienošanās, pārņemšana

Airbus Unit Satair to Buy Unical Aviation From Platinum Equity

2025. g. 7. nov. 17:09 UTC

Tirgus saruna

PENN Is Falling Further Behind Competitors -- Market Talk

2025. g. 7. nov. 16:49 UTC

Tirgus saruna

Losing ESPN Partnership Will Hurt PENN -- Market Talk

2025. g. 7. nov. 16:24 UTC

Tirgus saruna

OPEC+'s Output Hike Pause Comes Amid Excess Supply, Lower Spare Capacity -- Market Talk

2025. g. 7. nov. 16:17 UTC

Tirgus saruna

Oil Market Faces Oversupply But "Glut" Might Be Overblown -- Market Talk

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

158.62% augšup

Prognoze 12 mēnešiem

Vidējais 3 USD 158.62%

Augstākais 3 USD

Zemākais 3 USD

Pamatojoties uz 1 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

1 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 1 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.